Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
about
Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease RecurrenceCurrent Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous SystemCirculating glioma biomarkersInvestigation of serum proteome alterations in human glioblastoma multiforme.Secretome signature of invasive glioblastoma multiformeProtein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines.Proteomics and ovarian cancer: integrating proteomics information into clinical careInsights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluidTargeted tissue proteomic analysis of human astrocytomas.Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model.Emerging treatment strategies for glioblastoma multiformeProteomics of gliomas: initial biomarker discovery and evolution of technology.Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.Towards developing biomarkers for glioblastoma multiforme: a proteomics view.Liquid biopsies in patients with diffuse glioma.Emerging circulating biomarkers in glioblastoma: promises and challenges.Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.Multi-pronged proteomic analysis to study the glioma pathobiology using cerebrospinal fluid samples.
P2860
Q26774502-89FE7016-7F85-42F6-B8FA-7B34874767CFQ26796208-695F08E7-849F-4A8C-B5B5-CBD90C2DB3E2Q26830329-331FB153-2369-407C-ACB2-2B0A04469415Q31063977-5DA4026E-C770-47D2-A2CA-EB9A9495070DQ33901250-4DA03319-5ED2-4AFF-A8EB-D21A099AD830Q34042498-91E89DDC-879C-49E4-89E0-20B47CAEE142Q34126627-FC1C5C08-B877-4134-9D81-9635BA54852EQ34228023-AB7BC8F5-7184-4ED9-A636-5556B34FF247Q34337155-9FE5CE26-C5D7-4C83-8E1F-4D2CC800D0BFQ34490428-88C00B87-72B4-4C30-8657-80574D9C8ABFQ34542656-F07547E4-239D-456E-A8C6-1192BEF65843Q35170365-4B45EC18-47F6-4744-8DD7-8D9EF1D6F91AQ36579481-66F84078-6C5B-43F9-8C2C-C8A8B026227FQ38207538-2521E798-7FB7-4237-B9A4-A23FCDF7A5A2Q38208182-98365955-3949-4BD2-ACE4-413E1D34D294Q38239173-1FE9C5AE-825B-4A54-AC78-6EA198338173Q38365590-96864739-3575-40BA-97B6-C14C9A1DA074Q38591062-DCEF36DF-07EB-4441-BE11-287303F3EEEBQ38702839-23A142B5-1431-48B3-A79F-8CDF8DE394F7Q38844925-8A6EA6F5-D44C-4FEB-A6DB-B1BC2D0E1B31Q39178864-FC079443-5859-4C25-9BBB-20407E3244CFQ44190698-A283153A-D341-45B2-A6AB-018C04586EAEQ47763379-62126021-C2CE-41FB-9118-AF5F3322AEB9Q48173688-06F94011-B78B-4ABD-9AB6-3810CEC6BC7C
P2860
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
@ast
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
@en
type
label
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
@ast
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
@en
prefLabel
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
@ast
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
@en
P2093
P1476
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
@en
P2093
C G Schneekloth
H J Stuerenburg
M U Schuhmann
P304
P356
10.1016/J.EJSO.2009.07.010
P577
2009-08-11T00:00:00Z